Advanced search
Publication Cover
Paediatrics and International Child Health Volume 38, 2018 - Issue 4
Submit an article Journal homepage
409
Views
0
CrossRef citations to date
0
Altmetric
Articles

Three-monthly bolus vitamin D supplements (1000 vs 400 IU/day) for prevention of bone loss in children with difficult-to-treat nephrotic syndrome: a randomised clinical trial

Dhurva Nandan SinghDepartments of Pediatrics, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry, IndiaView further author information
,
Sriram KrishnamurthyDepartments of Pediatrics, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry, IndiaCorrespondence[email protected]
View further author information
,
Sadish Kumar KamalanathanEndocrinology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry, IndiaView further author information
,
K. T. HarichandrakumarBiostatistics, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry, IndiaView further author information
&
Palanisamy SivamurukanDepartments of Pediatrics, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry, IndiaView further author information
Pages 251-260 | Received 04 Jul 2017, Accepted 24 Jul 2018, Published online: 09 Aug 2018

References

  • Bagga A, Ali U, Banerjee S, et al. Management of steroid sensitive nephrotic syndrome: revised guidelines. Indian Pediatr. 2008;45:203–214.
  • Choudhary S, Agarwal I, Seshadri MS. Calcium and vitamin D for osteoprotection in children with new-onset nephrotic syndrome treated with steroids: a prospective, randomized, controlled, interventional study. Pediatr Nephrol. 2014;29:1025–1032.
  • Bak M, Serdaroglu E, Guclu R. Prophylactic calcium and vitamin D treatments in steroid-treated children with nephrotic syndrome. Pediatr Nephrol. 2006;21:350–354.
  • Gulati S, Sharma RK, Gulati K, et al. Longitudinal follow-up of bone mineral density in children with nephrotic syndrome and the role of calcium and vitamin D supplements. Nephrol Dial Transplant. 2005;20:1598–1603.
  • Misra M, Pacaud D, Petryk A, et al. Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics. 2008;122:398–417.
  • Calikoglu AS, Davenport ML. Prophylactic vitamin D supplementation. Endocr Dev. 2003;6:233–258.
  • Rathi N, Vitamin RA. D and child health in the 21st century. Indian Pediatr. 2011;48:619–625.
  • Muske S, Krishnamurthy S, Kamalanathan SK, et al. Effect of two prophylactic bolus vitamin D dosing regimens (1000 IU/day vs. 400 IU/day) on bone mineral content in new-onset and infrequently-relapsing nephrotic syndrome: a randomised clinical trial. Paediatr Int Child Health. 2018;38:23–33.
  • Gulati A, Bagga A, Gulati S, et al. Management of steroid resistant nephrotic syndrome. Indian Pediatr. 2009;46:35–47.
  • Bagga A, Mantan M. Nephrotic syndrome in children. Indian J Med Res. 2005;122:13–28.
  • Rosenthal R. Parametric measures of effect size. In: Cooper H, Hedges LV, Valentine JC, editors. The Handbook of Research Synthesis. 1994. p. 231–244. New York: Russell Sage Foundation.
  • Ribeiro D, Zawadynski S, Pittet LF, et al. Effect of glucocorticoids on growth and bone mineral density in children with nephrotic syndrome. Eur J Pediatr. 2015;174:911–917.
  • Mushtaq T, Ahmed SF. The impact of corticosteroids on growth and bone health. Arch Dis Child. 2002;87:93–96.
  • Friedman M, Strang LB. Effect of long-term corticosteroids and corticotrophin on the growth of children. Lancet. 1966;2:569–572.
  • Allen DB. Growth suppression by glucocorticoid therapy. Endocrinol Metab Clin North Am. 1996;25:699–717.
  • Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266–281.
  • Pańczyk-Tomaszewska M, Adamczuk D, Kisiel A, et al. Markers of bone metabolism in children with nephrotic syndrome treated with corticosteroids. Adv Exp Med Biol. 2015;840:21–28.
  • Heaney RP. Bone mineral content, not bone mineral density, is the correct bone measure for growth studies. Am J Clin Nutr. 2003;78:350–351; author reply 351–352.
  • Prentice A, Parsons TJ, Cole TJ. Uncritical use of bone mineral density in absorptiometry may lead to size-related artifacts in the identification of bone mineral determinants. Am J Clin Nutr. 1994;60:837–842.
  • Freundlich M, Bourgoignie JJ, Zilleruelo G, et al. Calcium and vitamin D metabolism in children with nephrotic syndrome. J Pediatr. 1986;108:383–387.
  • Freundlich M, Bourgoignie JJ, Zilleruelo G, et al. Bone modulating factors in nephrotic children with normal glomerular filtration rate. Pediatrics. 1985;76:280–285.
  • Weng FL, Shults J, Herskovitz RM, et al. Vitamin D insufficiency in steroid-sensitive nephrotic syndrome in remission. Pediatr Nephrol. 2005;20:56–63.
  • Wetzsteon RJ, Shults J, Zemel BS, et al. Divergent effects of glucocorticoids on cortical and trabecular compartment BMD in childhood nephrotic syndrome. J Bone Miner Res. 2009;24:503–513.
  • Grymonprez A, Proesmans W, Van Dyck M, et al. Vitamin D metabolites in childhood nephrotic syndrome. Pediatr Nephrol. 1995;9:278–281.
  • Ilahi M, Armas LAG, Heaney RP. Pharmacokinetics of a single, large dose of cholecalciferol. Am J Clin Nutr. 2008;87:688–691.
  • Boonen S, Vanderschueren D, Haentjens P, et al. Calcium and vitamin D in the prevention and treatment of osteoporosis – a clinical update. J Intern Med. 2006;259:539–552.
  • Sanfelix-Genovés J, Gil-Guillén VF, Orozco-Beltran D, et al. Determinant factors of osteoporosis patients’ reported therapeutic adherence to calcium and/or vitamin D supplements: a cross-sectional, observational study of postmenopausal women. Drugs Aging. 2009;26:861–869.
  • Stephens WP, Klimiuk PS, Berry JL, et al. Annual high-dose vitamin D prophylaxis in Asian immigrants. Lancet. 1981;2:1199–1202.
  • Ish-Shalom S, Segal E, Salganik T, et al. Comparison of daily, weekly, and monthly vitamin D3 in ethanol dosing protocols for two months in elderly hip fracture patients. J Clin Endocrinol Metab. 2008;93:3430–3435.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.